Asia Pacific accounted for approximately 46,000 AML cases in 2020, with China, India, and Japan accounting for 40% of the global cases.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more